Abstract
Prostate cancer is the most common cancer in men and the second most common cause of cancer-related mortality in males [1]. Ninety-five percent of prostate cancer cases are diagnosed between 45 and 89 years of age (mean: 72 years). The incidence of prostate cancer increases with age, and the risk of developing it is 1/10,000 before 40 years of age, 1/103 between 40 and 59 years of age, 1/8 between 60 and 79 years of age [2]. The risk of prostate cancer in a man over the course of his lifetime is nearly 10%.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Garnick MB (1993) Prostate cancer: screening, diagnosis, and management. Ann Intern Med 118(10):804–818
American Cancer Society (2008) American Cancer Society: cancer facts and figures 2008. American Cancer Society, Atlanta, GA
Augustin H, Erbersdobler A, Hammerer PG, Graefen M, Huland H (2004) Prostate cancers in the transition zone: part 2; clinical aspects. BJU Int 94(9):1226–1229 (review)
Kurokawa K, Suzuki T, SuzukI K, Terada N, Ito K, Yoshikawa D, Arai Y, Yamanaka H (2003) Preliminary results of a monitoring system to confirm the preservation of cavernous nerves. Int J Urol 10(3):136–140
Ali M, Johnson IP, Hobson J, Mohammadi B, Khan F (2004) Anatomy of the pelvic plexus and innervation of the prostate gland. Clin Anat 17(2):123–129
Algaba F, Epstein JI, Aldape HC et al (1996) Assessment of prostate carcinoma in core needle biopsy–definition of minimal criteria for the diagnosis of cancer in biopsy material. Cancer 78(2):376–381
Konishi N, Shimada K, Ishida E, Nakamura M (2005) Molecular pathology of prostate cancer. Pathol Int 55(9):531–539 (review)
Gleason DF (1977) Histologic grading and clinical staging of prostatic carcinoma. In: Tannenbaum M (ed) Urologic pathology: the prostate. Lea & Febiger, Philadelphia, PA, pp 171–197
Reynolds MA, Kastury K, Groskopf J, Schalken JA, Rittenhouse H (2007) Molecular markers for prostate cancer. Cancer Lett 249(1):5–13 (review)
Presti JR (2000) Neoplasm of the prostate gland. In: Tanagho EA, McAninch JW (eds) Smith’s general urology, 15th edn. McGraw-Hill, San Francisco, pp 399–421
Akyol F, Ozyigit G, Selek U, Karabulut E (2005) PSA bouncing after short term androgen deprivation and 3D-conformal radiotherapy for localized prostate adenocarcinoma and the relationship with the kinetics of testosterone. Eur Urol 48:40–45
AJCC (2010) Prostate. In: Edge SB, et al. American Joint Committee on Cancer. AJCC cancer staging manual, 7th edn. New York: Springer, p 457
Kiyoshima K, Yokomizo A, Yoshida T, Tomita K, Yonemasu H, Nakamura M, Oda Y, Naito S, Hasegawa Y (2004) Anatomical features of periprostatic tissue and its surroundings: a histological analysis of 79 radical retropubic prostatectomy specimens. Jpn J Clin Oncol 34(8):463–468
Woods ME, Ouwenga M, Quek ML (2007) The role of pelvic lymphadenectomy in the management of prostate and bladder cancer. ScientificWorldJournal 7:789–799 (review)
Coleman RE (2007) Emerging strategies in bone health management for the adjuvant patient. Semin Oncol 34(6 suppl 4):S11–S16 (review)
Hansen EK, Roach M III (2006) Handbook of evidence-based radiation oncology. Springer, US, pp 297–298
Grubb RL III, Vardi IY, Bhayani SB, Kibel AS (2006) Minimally invasive approaches to localized prostate carcinoma. Hematol Oncol Clin North Am 20(4):879–895. (review)
Villavicencio H, Segarra J (2006) Perineal prostatectomy. Ann Urol (Paris) 40(5):317–327 (review)
Roach M III (2003) Hormonal therapy and radiotherapy for localized prostate cancer: who, where and how long? J Urol 170(6 pt 2):S35–S40; discussion S40–S41 (review)
Khan FM (2007) Treatment planning in radiation oncology, 2nd edn. Lippincott Williams & Wilkins, Philadelphia, p 128
Fiks T, Sporny S (1985) Klinefelter’s syndrome and neoplasms. Wiad Lek 38(17):1223–1226 (review)
Woodward PJ, Heidenreich A, Looijenga LHJ et al (2004) Germ cell tumours. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds) Pathology and genetics of tumours of the urinary system and male genital organs. IARC Press, Lyon, France, pp 221–249
Bosl GJ, Bajorin DF, Sheinfeld J et al (2005) Cancer of the testis. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 7th edn. Lippincott Williams & Wilkins, Philadelphia, PA, pp 1269–1290
Segal R, Lukka H, Klotz LH, Eady A, Bestic N, Johnston M; Cancer Care Ontario Practice Guidelines Initiative Genitourinary Cancer Disease Site Group (2001) Surveillance programs for early stage non-seminomatous testicular cancer: a practice guideline. Can J Urol 8(1):1184–1192 (review)
AJCC (2010) Testis. In: Edge SB, et al. American Joint Committee on Cancer. AJCC cancer staging manual, 7th edn. New York: Springer, p 469
Hansen EK, Roach M III (2006) Handbook of evidence-based radiation oncology. Springer, US, p 328
Shabbir M, Morgan RJ (2004) Testicular cancer. J R Soc Health 124(5):217–218 (review)
Naysmith TE, Blake DA, Harvey VJ, Johnson NP (1998) Do men undergoing sterilizing cancer treatments have a fertile future? Hum Reprod 13(11):3250–3255
Madeb R, Golijanin D, Knopf J, Messing EM (2007) Current state of screening for bladder cancer. Expert Rev Anticancer Ther 7(7):981–987 (review)
Mostofi FK, Davis CJ, Sesterhenn IA (1988) Pathology of tumors of the urinary tract. In: Skinner DG, Lieskovsky G (eds) Diagnosis and management of genitourinary cancer. WB Saunders, Philadelphia, PA, pp 83–117
AJCC (2010) Urinary bladder. In: Edge SB, et al. American Joint Committee on Cancer. AJCC cancer staging manual, 7th edn. New York: Springer, p 497
Soloway MS (1983) The management of superficial bladder cancer. In: Javadpour N (ed) Principles and management of urologic cancer, 2nd edn. Williams and Wilkins, Baltimore, MD, pp 446–467
Epstein JI (2003) The new World Health Organization/International Society of Urological Pathology (WHO/ISUP) classification for TA, T1 bladder tumors: is it an improvement? Crit Rev Oncol Hematol 47(2):83–89 (review)
Hansen EK, Roach M III (2006) Handbook of evidence-based radiation oncology. Springer, US, pp 286–287
Schulsinger AR, Allison RR, Choi WH (2006) Bladder cancer. In: Levitt SH, Purdy JA, Perez CA, Vijayakumar S (eds) Technical basis of radiation therapy. Springer, New York, pp 574–575
Levitt SH, Purdy JA, Perez CA (2006) Technical basis of radiation therapy, 4th revised edition. Springer, Berlin
Greene FL, Page DL, Fleming ID et al (2002) American Joint Committee on Cancer: AJCC cancer staging manual, 6th edn. Springer, New York
Hofker MH, van Deursen J (2002) Transgenic Mouse: Methods and Protocols, 1st edition, Humana Press, New Jersey
Pearse M, Morton GJ (2006) Testicular cancer. In: Perez C, Vijayakumar S (eds) Technical basis of radiation therapy, 4th revised edition. Springer, Berlin
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ozyigit, G., Beyzadeoglu, M., Ebruli, C. (2010). Genitourinary System Cancers. In: Basic Radiation Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-11666-7_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-11666-7_8
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-11665-0
Online ISBN: 978-3-642-11666-7
eBook Packages: MedicineMedicine (R0)